Larry Biegelsen
Stock Analyst at Wells Fargo
(3.88)
# 662
Out of 5,090 analysts
350
Total ratings
56.45%
Success rate
7.37%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintains: Equal-Weight | $72 → $82 | $81.40 | +0.74% | 20 | Dec 5, 2025 | |
| EW Edwards Lifesciences | Maintains: Overweight | $95 → $96 | $86.19 | +11.38% | 18 | Dec 5, 2025 | |
| MDT Medtronic | Maintains: Overweight | $100 → $114 | $101.36 | +12.47% | 19 | Nov 19, 2025 | |
| SYK Stryker | Maintains: Overweight | $452 → $456 | $364.02 | +25.27% | 17 | Nov 14, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $16 → $17 | $16.82 | +1.07% | 9 | Nov 14, 2025 | |
| MMSI Merit Medical Systems | Maintains: Overweight | $103 → $95 | $83.43 | +13.87% | 12 | Nov 14, 2025 | |
| TFX Teleflex | Maintains: Equal-Weight | $131 → $114 | $120.50 | -5.39% | 7 | Nov 7, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Equal-Weight | $13 → $14 | $20.92 | -33.08% | 11 | Nov 7, 2025 | |
| RXST RxSight | Maintains: Equal-Weight | $9 → $10 | $12.63 | -20.82% | 15 | Nov 6, 2025 | |
| INSP Inspire Medical Systems | Upgrades: Overweight | $101 → $90 | $136.81 | -34.22% | 14 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $93 | $65.49 | +42.01% | 10 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $120 → $122 | $108.51 | +12.43% | 17 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $89 → $87 | $85.46 | +1.80% | 5 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $124 → $125 | $97.52 | +28.18% | 15 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $599 → $600 | $575.34 | +4.29% | 21 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $170 → $212 | $201.93 | +4.99% | 14 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $0.68 → $0.85 | $1.08 | -21.30% | 6 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Equal-Weight | $93 | $80.73 | +15.20% | 9 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $3 | $2.01 | +49.25% | 7 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $24 | $18.54 | +29.45% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $315 → $290 | $300.66 | -3.55% | 19 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $40 → $15 | $12.11 | +19.74% | 18 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $27 | $24.07 | +12.17% | 2 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $113 → $98 | $94.28 | +3.95% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $16.40 | +3.66% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $13.23 | +270.37% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $125.08 | +8.73% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $91.10 | -23.16% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $193.96 | +39.20% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $63.30 | - | 2 | Nov 2, 2017 |
The Cooper Companies
Dec 5, 2025
Maintains: Equal-Weight
Price Target: $72 → $82
Current: $81.40
Upside: +0.74%
Edwards Lifesciences
Dec 5, 2025
Maintains: Overweight
Price Target: $95 → $96
Current: $86.19
Upside: +11.38%
Medtronic
Nov 19, 2025
Maintains: Overweight
Price Target: $100 → $114
Current: $101.36
Upside: +12.47%
Stryker
Nov 14, 2025
Maintains: Overweight
Price Target: $452 → $456
Current: $364.02
Upside: +25.27%
Bausch + Lomb
Nov 14, 2025
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $16.82
Upside: +1.07%
Merit Medical Systems
Nov 14, 2025
Maintains: Overweight
Price Target: $103 → $95
Current: $83.43
Upside: +13.87%
Teleflex
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $131 → $114
Current: $120.50
Upside: -5.39%
Tandem Diabetes Care
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $13 → $14
Current: $20.92
Upside: -33.08%
RxSight
Nov 6, 2025
Maintains: Equal-Weight
Price Target: $9 → $10
Current: $12.63
Upside: -20.82%
Inspire Medical Systems
Nov 4, 2025
Upgrades: Overweight
Price Target: $101 → $90
Current: $136.81
Upside: -34.22%
Oct 31, 2025
Maintains: Overweight
Price Target: $98 → $93
Current: $65.49
Upside: +42.01%
Oct 30, 2025
Maintains: Overweight
Price Target: $120 → $122
Current: $108.51
Upside: +12.43%
Oct 30, 2025
Maintains: Overweight
Price Target: $89 → $87
Current: $85.46
Upside: +1.80%
Oct 23, 2025
Maintains: Overweight
Price Target: $124 → $125
Current: $97.52
Upside: +28.18%
Oct 22, 2025
Maintains: Overweight
Price Target: $599 → $600
Current: $575.34
Upside: +4.29%
Oct 3, 2025
Upgrades: Overweight
Price Target: $170 → $212
Current: $201.93
Upside: +4.99%
Aug 15, 2025
Maintains: Equal-Weight
Price Target: $0.68 → $0.85
Current: $1.08
Upside: -21.30%
Aug 6, 2025
Reinstates: Equal-Weight
Price Target: $93
Current: $80.73
Upside: +15.20%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $6 → $3
Current: $2.01
Upside: +49.25%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $33 → $24
Current: $18.54
Upside: +29.45%
Jul 30, 2025
Maintains: Overweight
Price Target: $315 → $290
Current: $300.66
Upside: -3.55%
Jul 25, 2025
Downgrades: Equal-Weight
Price Target: $40 → $15
Current: $12.11
Upside: +19.74%
Jul 17, 2025
Maintains: Overweight
Price Target: $28 → $27
Current: $24.07
Upside: +12.17%
May 6, 2025
Maintains: Equal-Weight
Price Target: $113 → $98
Current: $94.28
Upside: +3.95%
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $16.40
Upside: +3.66%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $13.23
Upside: +270.37%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $125.08
Upside: +8.73%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $91.10
Upside: -23.16%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $193.96
Upside: +39.20%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $63.30
Upside: -